跳至主要内容
临床试验/JPRN-UMIN000002921
JPRN-UMIN000002921已完成未知

Evaluation of long-term management of pediatric bronchial asthma – Effects of bronchodilators in combination of antileukotrienes – - PAB

PARG (Pediatric Asthma Research Group)0 个研究点目标入组 140 人开始时间: 2009年12月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4years-old 至 12years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  •  Children who are receiving long-acting beta2 agonists (tulobuterol patch or inhaled salmeterol) or oral beta2 agonists regularly.  Children with a history of hypersensitivity to tulobuterol patch, and children with dermal diseases such as atopic dermatitis for whom treatment with tulobuterol patch are considered inappropriate.  Children with hyperthyroidism, hypertension, heart disease or diabetes mellitus for whom treatment with beta2 agonists is considered inappropriate.  Children with a history of serious adverse effects of tulobuterol. Children with a history of serious adverse effects of theophylline.  Children with epilepsy, hyperthyroidism, acute nephritis, congestive heart failure or liver disorder for whom treatment with theophylline is considered inappropriate.  Children with neurological dispositions (e.g., epilepsy, convulsions and abnormal EEG)  Children with fever  Any other children for whom participation in the survey is considered inappropriate by the attending physicians.

研究者

发起方
PARG (Pediatric Asthma Research Group)

相似试验